When was BioCircuit founded?

BioCircuit was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is BioCircuit located?

BioCircuit is headquartered in Atlanta, United States.

How many employees does BioCircuit have?

As of Sep 30, 2026, the latest employee count at BioCircuit is 46.

Is BioCircuit a funded company?

BioCircuit is a funded company, having raised a total of $13.6M across 10 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on May 15, 2019.

When was the latest funding round of BioCircuit?

BioCircuit's latest funding was a $***** Grant (prize money) round on Aug 28, 2025, with participation from 1 investor.

Where does BioCircuit rank among its competitors?

BioCircuit ranks 2nd amongst 16 active competitors, of which 7 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was AxoGen, which secured $1.21M in Oct, 2025.

Who are the top competitors of BioCircuit?

BioCircuit's top competitors include AxoGen, Tulavi Nerve Therapeutics and RxFunction. Among them, AxoGen secured the most recent funding round in October, 2025.

BioCircuit - 2026 Company Profile, Funding & Competitors

Q: Is BioCircuit an acquired company?

BioCircuit got acquired by AxoGen on Sep 10, 2026.

BioCircuit is an acquired company based in Atlanta (United States), founded in 2016. It operates as a Developer of non-invasive electrophysiology devices to monitor peripheral nerves. BioCircuit has raised $13.6M in funding from Masters Capital Management. The company has 16 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like AxoGen, Tulavi Nerve Therapeutics and RxFunction.

Company Details

Developer of non-invasive electrophysiology devices to monitor peripheral nerves. The company is developed a multielectrode array-based technology that uses proprietary algorithms to test peripheral nerve activity.

Website: www.biocircuit.com/
Email ID: *****@biocircuit.com

Key Metrics

Founded Year

2016

Location

Atlanta, United States

Stage

Acquired

Total Funding

$13.6M in 10 rounds

Latest Funding Round

Grant (prize money), Aug 28, 2025, $*****

Investors

Masters Capital Management & 5 more

Ranked

2^nd among 16 active competitors

Employee Count

46 as on Sep 30, 2026

Similar Companies

AxoGen & 18 more

Exit Details

Acquired by AxoGen (Sep 10, 2026)

View BioCircuit's full profile

BioCircuit is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BioCircuit Technologies CIN: 46-3077590 , United States, Active	Dec 31, 2018	-	-	-

BioCircuit got acquired by AxoGen on Sep 10, 2026 at an acquisition amount of $*****.

Click here to take a look at BioCircuit's acquisition in detail

BioCircuit has raised a total funding of $13.6M over 10 rounds. Its first funding round was on May 15, 2019. Its latest funding round was a Grant (prize money) round on Aug 28, 2025 for $*****. 1 investor participated in its latest round. BioCircuit has 6 institutional investors.

Here is the list of recent funding rounds of BioCircuit:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 28, 2025	6273228	Grant (prize money)	3342574	8933921	7085084	2672247
May 07, 2025	8861459	Grant (prize money)	1238198	1146349	2401857	HHS
Mar 21, 2025	3671960	Grant (prize money)	9833852	9393960	9820688	HHS

Access funding benchmarks and valuations. Sign up today!

View details of BioCircuit's funding rounds and investors

BioCircuit's employee count trend

BioCircuit has 46 employees as of Sep 26. Here is BioCircuit's employee count trend over the years:

Uncover BioCircuit's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioCircuit include AxoGen, Tulavi Nerve Therapeutics and RxFunction. Here is the list of Top 10 competitors of BioCircuit, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AxoGen 2002, Alachua (United States), Public	Developer of therapies for the repair of peripheral nerve injuries	$62.4M	Oberland Capital, Cardinal Partners & 10 others	65/100
2nd	BioCircuit 2016, Atlanta (United States), Acquired	Developer of non-invasive electrophysiology devices to monitor peripheral nerves	$13.6M	GRA Venture Fund, Masters Capital Management ... & 4 others	58/100
3rd	Tulavi Nerve Therapeutics 2020, Mountain View (United States), Series A	Developer of the therapeutic device to treat neurally mediated diseases	$11.5M	Ascension Ventures, AMED Ventures & 1 others	57/100
4th	RxFunction 2010, Minneapolis (United States), Series B	Provider of wearable prosthesis for people with sensory peripheral neuropathy	$39.9M	Cedar Point Capital, HHS	43/100
5th	Renerva 2017, Pittsburgh (United States), Seed	Surgical solutions advancing nerve recovery, restoring hope after nerve injury	$1.28M	Defense.gov, America’s Seed Fund & 4 others	42/100
6th	Epineuron 2016, Hamilton (Canada), Seed	Provider of medical devices for peripheral nerve injury treatment	-	Ontario Centre of Innovation, Ontario Brain Institute ... & 4 others	37/100
7th	Newrotex 2019, Oxford (United Kingdom), Funding Raised	Provider of silk-based solutions for the treatment of peripheral nerve injuries	-	EIC Fund, MedTech Innovator	35/100
8th	Monarch Bioimplants 2016, Root (Switzerland), Series B	Developer of bioimplant for peripheral nerve repair	$24.9M	Global Emerging Markets, FastTrack Ventures	34/100
9th	Micro Leads 2014, Boston (United States), Seed	Precision neuromodulation therapies using minimally-invasive, high-resolution devices for nervous system interfaces	-	Massachusetts Life Sciences Center, GSK & 4 others	33/100
10th	PhotoThera 1997, Carlsbad (United States), Deadpooled	Laser therapies	$80.5M	The Vertical Group, Warburg Pincus & 5 others	31/100